[DPHARMA] QoQ TTM Result on 31-Dec-2014 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
QoQ- 5.33%
YoY- 6.55%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Revenue 232,663 197,750 182,065 176,961 171,671 167,697 165,062 25.68%
PBT 46,157 45,813 47,513 46,490 41,729 39,496 42,396 5.82%
Tax -8,786 -8,393 -8,428 -8,009 -7,856 -7,519 -7,243 13.72%
NP 37,371 37,420 39,085 38,481 33,873 31,977 35,153 4.15%
-
NP to SH 34,569 34,618 36,283 35,679 33,873 31,977 35,153 -1.10%
-
Tax Rate 19.04% 18.32% 17.74% 17.23% 18.83% 19.04% 17.08% -
Total Cost 195,292 160,330 142,980 138,480 137,798 135,720 129,909 31.19%
-
Net Worth 268,530 189,815 205,045 192,951 187,531 179,145 190,050 25.89%
Dividend
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Div 25,710 25,710 25,682 25,682 24,291 24,291 24,289 3.85%
Div Payout % 74.38% 74.27% 70.79% 71.98% 71.71% 75.97% 69.10% -
Equity
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Net Worth 268,530 189,815 205,045 192,951 187,531 179,145 190,050 25.89%
NOSH 278,959 139,570 139,486 138,813 138,912 138,872 138,723 59.24%
Ratio Analysis
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
NP Margin 16.06% 18.92% 21.47% 21.75% 19.73% 19.07% 21.30% -
ROE 12.87% 18.24% 17.70% 18.49% 18.06% 17.85% 18.50% -
Per Share
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 139.50 141.68 130.52 127.48 123.58 120.76 118.99 11.17%
EPS 20.73 24.80 26.01 25.70 24.38 23.03 25.34 -12.51%
DPS 15.42 18.50 18.50 18.50 17.50 17.50 17.50 -8.08%
NAPS 1.61 1.36 1.47 1.39 1.35 1.29 1.37 11.35%
Adjusted Per Share Value based on latest NOSH - 138,813
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 24.17 20.54 18.91 18.38 17.83 17.42 17.15 25.67%
EPS 3.59 3.60 3.77 3.71 3.52 3.32 3.65 -1.09%
DPS 2.67 2.67 2.67 2.67 2.52 2.52 2.52 3.92%
NAPS 0.2789 0.1972 0.213 0.2004 0.1948 0.1861 0.1974 25.88%
Price Multiplier on Financial Quarter End Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 -
Price 2.72 2.65 3.88 2.50 3.17 2.97 3.03 -
P/RPS 1.95 1.87 2.97 1.96 2.57 2.46 2.55 -16.36%
P/EPS 13.12 10.68 14.92 9.73 13.00 12.90 11.96 6.35%
EY 7.62 9.36 6.70 10.28 7.69 7.75 8.36 -5.98%
DY 5.67 6.98 4.77 7.40 5.52 5.89 5.78 -1.27%
P/NAPS 1.69 1.95 2.64 1.80 2.35 2.30 2.21 -16.36%
Price Multiplier on Announcement Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 24/11/15 25/08/15 18/05/15 24/02/15 21/11/14 26/08/14 20/05/14 -
Price 2.70 2.40 3.90 2.92 3.01 3.37 3.09 -
P/RPS 1.94 1.69 2.99 2.29 2.44 2.79 2.60 -17.71%
P/EPS 13.03 9.68 14.99 11.36 12.34 14.64 12.19 4.53%
EY 7.68 10.33 6.67 8.80 8.10 6.83 8.20 -4.26%
DY 5.71 7.71 4.74 6.34 5.81 5.19 5.66 0.58%
P/NAPS 1.68 1.76 2.65 2.10 2.23 2.61 2.26 -17.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment